{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:50:55Z","timestamp":1794851455079,"version":"4.9.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Greece and the European Union"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Chronic inflammatory diseases, like Systemic Lupus Erythematosus (SLE), carry an increased risk for atherosclerosis and cardiovascular events, accompanied by impairment of atheroprotective properties of high-density lipoprotein (HDL). In SLE, serum B cell-activating factor (BAFF), a cytokine implicated in disease progression, has been correlated with subclinical atherosclerosis. We investigated the impact of treatment with belimumab -an anti-BAFF monoclonal antibody- on HDL atheroprotective properties and composition in SLE patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum samples were collected from 35 SLE patients with active disease despite conventional therapy, before and after 6-month add-on treatment with belimumab, and 26 matched healthy individuals. We measured cholesterol efflux and antioxidant capacities, paraoxonase-1 (PON1) activity, serum amyloid A1 (SAA1), myeloperoxidase (MPO) and lipid peroxidation product levels of HDL. LC-MS\/MS was performed to analyse the HDL lipidome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Following treatment with belimumab, cholesterol efflux and antioxidant capacities of HDL were significantly increased in SLE patients and restored to levels of control subjects. HDL-associated PON1 activity was also increased, whereas lipid peroxidation products were decreased following treatment. HDL cholesterol efflux and antioxidant capacities correlated negatively with the disease activity. Changes were noted in the HDL lipidome of SLE patients following belimumab treatment, as well as between SLE patients and healthy individuals, and specific changes in lipid species correlated with functional parameters of HDL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HDL of SLE patients with active disease displays impaired atheroprotective properties accompanied by distinct lipidomic signatures compared with controls. Belimumab treatment may improve the HDL atheroprotective properties and modify the HDL lipidomic signature in SLE patients, thus potentially mitigating atherosclerosis development.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae192","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T03:19:56Z","timestamp":1711077596000},"page":"648-657","source":"Crossref","is-referenced-by-count":21,"title":["Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment"],"prefix":"10.1093","volume":"64","author":[{"given":"Anastasia-Georgia","family":"Dedemadi","sequence":"first","affiliation":[{"name":"Institute of Biosciences and Applications, National Center for Scientific Research \u201cDemokritos\u201d , Agia Paraskevi, Athens,","place":["Greece"]},{"name":"Department of Chemistry, National and Kapodistrian University of Athens , Zografou, Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gkolfinopoulou","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Applications, National Center for Scientific Research \u201cDemokritos\u201d , Agia Paraskevi, Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Nikoleri","sequence":"additional","affiliation":[{"name":"Laboratory of Rheumatology, Autoimmunity and Inflammation, University of Crete Medical School , Heraklion,","place":["Greece"]},{"name":"Institute of Molecular Biology and Biotechnology, FORTH , Heraklion,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Nikoloudaki","sequence":"additional","affiliation":[{"name":"Laboratory of Rheumatology, Autoimmunity and Inflammation, University of Crete Medical School , Heraklion,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Ruhanen","sequence":"additional","affiliation":[{"name":"Helsinki University Lipidomics Unit, HiLIPID, Helsinki Institute of Life Science, HiLIFE, and Biocenter Finland , Helsinki,","place":["Finland"]},{"name":"Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki , Helsinki,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Holopainen","sequence":"additional","affiliation":[{"name":"Helsinki University Lipidomics Unit, HiLIPID, Helsinki Institute of Life Science, HiLIFE, and Biocenter Finland , Helsinki,","place":["Finland"]},{"name":"Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki , Helsinki,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"K\u00e4kel\u00e4","sequence":"additional","affiliation":[{"name":"Helsinki University Lipidomics Unit, HiLIPID, Helsinki Institute of Life Science, HiLIFE, and Biocenter Finland , Helsinki,","place":["Finland"]},{"name":"Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki , Helsinki,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Christopoulou","sequence":"additional","affiliation":[{"name":"Genotypos-Science Labs , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Bournazos","sequence":"additional","affiliation":[{"name":"Genotypos-Science Labs , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Constantoulakis","sequence":"additional","affiliation":[{"name":"Genotypos-Science Labs , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-0326","authenticated-orcid":false,"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[{"name":"Laboratory of Rheumatology, Autoimmunity and Inflammation, University of Crete Medical School , Heraklion,","place":["Greece"]},{"name":"Institute of Molecular Biology and Biotechnology, FORTH , Heraklion,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-1406","authenticated-orcid":false,"given":"George","family":"Bertsias","sequence":"additional","affiliation":[{"name":"Laboratory of Rheumatology, Autoimmunity and Inflammation, University of Crete Medical School , Heraklion,","place":["Greece"]},{"name":"Institute of Molecular Biology and Biotechnology, FORTH , Heraklion,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-1189","authenticated-orcid":false,"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Applications, National Center for Scientific Research \u201cDemokritos\u201d , Agia Paraskevi, Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"2025032905204920100_keae192-B1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"2025032905204920100_keae192-B2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11883-023-01149-4","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"25","author":"Tobin","year":"2023","journal-title":"Curr Atheroscler. Rep"},{"key":"2025032905204920100_keae192-B3","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur Heart J"},{"key":"2025032905204920100_keae192-B4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"key":"2025032905204920100_keae192-B5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"2025032905204920100_keae192-B6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.semarthrit.2020.05.011","article-title":"High-density lipoprotein functionality in systemic lupus erythematosus","volume":"50","author":"Ganjali","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905204920100_keae192-B7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/art.41059","article-title":"High-density lipoprotein in lupus: disease biomarkers and potential therapeutic strategy","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025032905204920100_keae192-B8","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025032905204920100_keae192-B9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann. Rheum. Dis"},{"key":"2025032905204920100_keae192-B10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/JIR.S399284","article-title":"Oxidative stress contributes to inflammatory and cellular damage in systemic lupus erythematosus: cellular markers and molecular mechanism","volume":"16","author":"Yan","year":"2023","journal-title":"J Inflamm Res"},{"key":"2025032905204920100_keae192-B11","doi-asserted-by":"crossref","first-page":"e0224496","DOI":"10.1371\/journal.pone.0224496","article-title":"Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity","volume":"14","author":"Hammad","year":"2019","journal-title":"PLoS One"},{"key":"2025032905204920100_keae192-B12","doi-asserted-by":"crossref","first-page":"694318","DOI":"10.3389\/fimmu.2021.694318","article-title":"Plasma sphingolipid profile associated with subclinical atherosclerosis and clinical disease markers of systemic lupus erythematosus: potential predictive value","volume":"12","author":"Hammad","year":"2021","journal-title":"Front Immunol"},{"key":"2025032905204920100_keae192-B13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0961203316686707","article-title":"Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study","volume":"26","author":"Checa","year":"2017","journal-title":"Lupus"},{"key":"2025032905204920100_keae192-B14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biom8040105","article-title":"Shotgun lipidomics revealed altered profiles of serum lipids in systemic lupus erythematosus closely associated with disease activity","volume":"8","author":"Lu","year":"2018","journal-title":"Biomolecules"},{"key":"2025032905204920100_keae192-B15","doi-asserted-by":"crossref","first-page":"102736","DOI":"10.1016\/j.autrev.2020.102736","article-title":"B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)","volume":"20","author":"Mockel","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2025032905204920100_keae192-B16","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/acr.24901","article-title":"Impact of belimumab on organ damage in systemic lupus erythematosus","volume":"74","author":"Urowitz","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025032905204920100_keae192-B17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/ATVBAHA.111.244731","article-title":"BAFF receptor deficiency reduces the development of atherosclerosis in mice\u2014brief report","volume":"32","author":"Sage","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025032905204920100_keae192-B18","doi-asserted-by":"crossref","first-page":"e29371","DOI":"10.1371\/journal.pone.0029371","article-title":"Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation","volume":"7","author":"Kyaw","year":"2012","journal-title":"PLoS One"},{"key":"2025032905204920100_keae192-B19","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.1601198","article-title":"Cutting edge: BAFF overexpression reduces atherosclerosis via TACI-dependent B cell activation","volume":"197","author":"Jackson","year":"2016","journal-title":"J. Immunol"},{"key":"2025032905204920100_keae192-B20","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.117.032790","article-title":"B cell-activating factor neutralization aggravates atherosclerosis","volume":"138","author":"Tsiantoulas","year":"2018","journal-title":"Circulation"},{"key":"2025032905204920100_keae192-B21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.41485","article-title":"Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus","volume":"73","author":"Saidoune","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025032905204920100_keae192-B22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-019-2015-7","article-title":"B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus","volume":"21","author":"Spinelli","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025032905204920100_keae192-B23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025032905204920100_keae192-B24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025032905204920100_keae192-B25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025032905204920100_keae192-B26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal Biochem"},{"key":"2025032905204920100_keae192-B27","doi-asserted-by":"crossref","first-page":"e011792","DOI":"10.1161\/JAHA.118.011792","article-title":"HDL phospholipids, but not cholesterol distinguish acute coronary syndrome from stable coronary artery disease","volume":"8","author":"Meikle","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025032905204920100_keae192-B28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jacl.2023.07.003","article-title":"Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia","volume":"17","author":"Darabi","year":"2023","journal-title":"J Clin Lipidol"},{"key":"2025032905204920100_keae192-B29","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025032905204920100_keae192-B30","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1093\/hmg\/ddy280","article-title":"Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans","volume":"27","author":"Hanscombe","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2025032905204920100_keae192-B31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-0039.2006.00735.x","article-title":"Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease","volume":"69","author":"Palikhe","year":"2007","journal-title":"Tissue Antigens"},{"key":"2025032905204920100_keae192-B32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00002281-199709000-00003","article-title":"Autoantibodies in systemic lupus erythematosus","volume":"9","author":"Cabral","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905204920100_keae192-B33","doi-asserted-by":"crossref","first-page":"108953","DOI":"10.1016\/j.clim.2022.108953","article-title":"Systemic lupus erythematosus as a genetic disease","volume":"236","author":"Harley","year":"2022","journal-title":"Clin Immunol"},{"key":"2025032905204920100_keae192-B34","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/rheumatology\/keaa038","article-title":"Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis","volume":"59","author":"S\u00e1nchez-P\u00e9rez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905204920100_keae192-B35","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/art.24677","article-title":"Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus","volume":"60","author":"McMahon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025032905204920100_keae192-B36","doi-asserted-by":"crossref","first-page":"e000321","DOI":"10.1136\/lupus-2019-000321","article-title":"Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE","volume":"6","author":"McMahon","year":"2019","journal-title":"Lupus Sci. Med"},{"key":"2025032905204920100_keae192-B37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/metabo10040163","article-title":"A review of lipidomics of cardiovascular disease highlights the importance of isolating lipoproteins","volume":"10","author":"Ding","year":"2020","journal-title":"Metabolites"},{"key":"2025032905204920100_keae192-B38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11306-020-01709-8","article-title":"Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis","volume":"16","author":"Seah","year":"2020","journal-title":"Metabolomics"},{"key":"2025032905204920100_keae192-B39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13105-019-00694-4","article-title":"Alterations of HDL particle phospholipid composition and role of inflammation in rheumatoid arthritis","volume":"75","author":"Giraud","year":"2019","journal-title":"J Physiol Biochem"},{"key":"2025032905204920100_keae192-B40","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905204920100_keae192-B41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.semarthrit.2018.02.014","article-title":"Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: a real-life observational study","volume":"48","author":"Fanouriakis","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905204920100_keae192-B42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.41253","article-title":"Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting","volume":"72","author":"Gatto","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae192\/57180334\/keae192.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/648\/57180334\/keae192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/648\/57180334\/keae192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:22:12Z","timestamp":1743391332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/648\/7633400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3,21]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae192","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,3,21]]}}}